SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden AS Rudberg, S Havervall, A Månberg, AJ Falk, K Aguilera, H Ng, ... Nature communications 11 (1), 1-8, 2020 | 325 | 2020 |
The human secretome M Uhlén, MJ Karlsson, A Hober, AS Svensson, J Scheffel, D Kotol, ... Science signaling 12 (609), 2019 | 321 | 2019 |
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments B Ayoglu, A Häggmark, M Khademi, T Olsson, M Uhlén, JM Schwenk, ... Molecular & Cellular Proteomics 12 (9), 2657-2672, 2013 | 101 | 2013 |
Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease PE Khoonsari, A Häggmark, M Lönnberg, M Mikus, L Kilander, L Lannfelt, ... PloS one 11 (3), e0150672, 2016 | 97 | 2016 |
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease J Remnestål, D Just, N Mitsios, C Fredolini, J Mulder, JM Schwenk, ... PROTEOMICS-Clinical Applications 10 (12), 1242-1253, 2016 | 91 | 2016 |
Altered perivascular fibroblast activity precedes ALS disease onset A Månberg, N Skene, F Sanders, M Trusohamn, J Remnestål, ... Nature medicine 27 (4), 640-646, 2021 | 85 | 2021 |
Proteomic profiling reveals autoimmune targets in sarcoidosis A Häggmark, C Hamsten, E Wiklundh, C Lindskog, C Mattsson, ... American journal of respiratory and critical care medicine 191 (5), 574-583, 2015 | 77 | 2015 |
Whole-proteome peptide microarrays for profiling autoantibody repertoires within multiple sclerosis and narcolepsy A Zandian, B Forsström, A Häggmark-Månberg, JM Schwenk, ... Journal of proteome research 16 (3), 1300-1314, 2017 | 73 | 2017 |
Systematic antibody and antigen-based proteomic profiling with microarrays B Ayoglu, A Häggmark, M Neiman, U Igel, M Uhlén, JM Schwenk, ... Expert review of molecular diagnostics 11 (2), 219-234, 2011 | 67 | 2011 |
Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis A Häggmark, M Mikus, A Mohsenchian, MG Hong, B Forsström, ... Annals of clinical and translational neurology 1 (8), 544-553, 2014 | 62 | 2014 |
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19 S Havervall, H Ng, A Jernbom Falk, N Greilert‐Norin, A Månberg, ... Journal of internal medicine 291 (1), 72-80, 2022 | 59 | 2022 |
Defining the human brain proteome using transcriptomics and antibody-based profiling with a focus on the cerebral cortex E Sjöstedt, L Fagerberg, BM Hallström, A Häggmark, N Mitsios, P Nilsson, ... PloS one 10 (6), e0130028, 2015 | 58 | 2015 |
Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis S Byström, B Ayoglu, A Häggmark, N Mitsios, MG Hong, K Drobin, ... Journal of proteome research 13 (11), 4607-4619, 2014 | 56 | 2014 |
Antibody‐based profiling of cerebrospinal fluid within multiple sclerosis A Häggmark, S Byström, B Ayoglu, U Qundos, M Uhlén, M Khademi, ... Proteomics 13 (15), 2256-2267, 2013 | 52 | 2013 |
Immunocapture strategies in translational proteomics C Fredolini, S Byström, E Pin, F Edfors, D Tamburro, MJ Iglesias, ... Expert review of proteomics 13 (1), 83-98, 2016 | 47 | 2016 |
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection S Havervall, A Jernbom Falk, J Klingström, H Ng, N Greilert-Norin, ... PLoS One 17 (1), e0262169, 2022 | 44 | 2022 |
Persisting salivary IgG against SARS-CoV-2 at 9 months after mild COVID-19: a complementary approach to population surveys H Alkharaan, S Bayati, C Hellström, S Aleman, A Olsson, K Lindahl, ... The Journal of infectious diseases 224 (3), 407-414, 2021 | 40 | 2021 |
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis KA Högelin, N Ruffin, E Pin, A Månberg, S Hober, G Gafvelin, H Grönlund, ... Iscience 24 (9), 103078, 2021 | 34 | 2021 |
Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers J Remnestål, L Öijerstedt, A Ullgren, J Olofsson, S Bergström, K Kultima, ... Translational neurodegeneration 9 (1), 1-13, 2020 | 34 | 2020 |
Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease A Andersson, J Remnestål, B Nellgård, H Vunk, D Kotol, F Edfors, ... Clinica Chimica Acta 494, 79-93, 2019 | 34 | 2019 |